JW Pharmaceutical has redesigned the bag and box packaging for its Winnerf total parenteral nutrition (TPN) product line to improve label clarity and reduce medication errors in hospital settings. The changes, driven by ongoing requests from the Korean Society of Health-System Pharmacists (KSHP), focus on enhancing visibility of product names, dosages, and administration routes. This move signals a growing trend in Korea where packaging safety is becoming a key differentiator for injectable and infusion product suppliers serving hospital pharmacies.
Packaging as a patient safety tool
KSHP’s Patient Safety and Quality Improvement Committee Chair Yoon Jeong-i emphasized that packaging is a critical component of patient safety for injectables. "In hospitals, injectables go through multiple steps—prescription, compounding, dispensing, and ward administration. If product name, content, total volume, and route are not clearly distinguishable, errors are likely," she said. The redesign directly addresses these concerns by enlarging key information on the TPN bag and adding route-of-administration markings above the infusion set port.
Color coding and box alignment
The new design introduces a consistent color-coding system across the Winnerf family: red for Winnerf, blue for Winnerf Feri, orange for Winnerf A+, and green for Winnerf A+ Feri. Previously, colors varied within the same product group, causing confusion. The box design now mirrors the bag’s color scheme and enlarges dosage and route markings, ensuring seamless identification from storage to bedside.
What buyers should watch
For overseas importers and distributors supplying TPN or other injectables to Korean hospitals, this case highlights that packaging safety is becoming a procurement requirement. Buyers should expect Korean hospital pharmacies to increasingly demand clear, color-coded, and route-labeled packaging for infusion products. Suppliers who proactively adopt similar design standards may gain a competitive edge in the Korean medical aesthetics and hospital supply market.
Regulatory and channel signals
KSHP has been advocating for packaging improvements across multiple drug categories, including basic IV fluids, narcotic injectables, and anticoagulants. Yoon noted that individual hospitals often lack the leverage to push changes, but collective demands through KSHP have prompted manufacturers like JW Pharmaceutical to act. This suggests that channel-level advocacy groups are becoming influential in shaping packaging standards, which could eventually affect import requirements for foreign suppliers.
Sourcing context
JW Pharmaceutical began collecting feedback from general hospitals in late 2024 and will roll out the redesigned products sequentially, depending on existing inventory. The company stated that the changes aim to reduce confusion during pre-administration checks and improve patient safety. For clinic buyers and distributors sourcing TPN products from Korea, verifying that suppliers have updated packaging to meet these new standards may become a due diligence item.
Source: Read the original report | Published: June 08, 2026